Piramal Pharma Ltd
BSE: 543635
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 1.5K+24.5% | 1.2K+6.1% | 1.1K+16.2% | 969.88-42.6% | 1.7K+35.4% | 1.2K-2.8% | 1.3K |
| Other Income | 183.69+91.0% | 96.15-52.4% | 201.97+11.6% | 180.92+357.9% | 39.51+60.0% | 24.70-76.8% | 106.38 |
| Total Income | 1.7K+29.5% | 1.3K-2.8% | 1.3K+15.5% | 1.2K-33.5% | 1.7K+35.8% | 1.3K-8.5% | 1.4K |
| EXPENSES | |||||||
| Expenditure | 1.3K+14.9% | 1.1K+2.6% | 1.1K+7.3% | 1.0K-26.1% | 1.4K+22.6% | 1.1K-0.1% | 1.1K |
| Tax | 70.22+169.9% | 26.02-49.1% | 51.08+73.5% | 29.44-66.2% | 87.09+114.5% | 40.61-38.1% | 65.65 |
| PROFIT | |||||||
| PBT | 331.85+114.2% | 154.93-37.4% | 247.41+73.5% | 142.58-60.9% | 364.36+128.6% | 159.41-42.2% | 275.71 |
| Net Profit | 261.63+103.0% | 128.91-34.3% | 196.33+73.5% | 113.14-59.2% | 277.27+133.4% | 118.80-43.4% | 210.06 |
| KEY METRICS | |||||||
| OPM % | 15.97%+4.24pp | 11.73%+0.46pp | 11.27%+6.70pp | 4.57%-20.08pp | 24.65%+20.64pp | 4.01%-2.67pp | 6.68% |
| NPM % | 15.64%+5.66pp | 9.98%-4.79pp | 14.77%+4.94pp | 9.83%-6.20pp | 16.03%+6.70pp | 9.33%-5.77pp | 15.10% |
| EPS | 1.97+103.1% | 0.97-34.5% | 1.48+74.1% | 0.85-59.3% | 2.09+132.2% | 0.90-43.4% | 1.59 |
Corporate Events
Board MeetingPPLPHARMA
202630Jul
Board Meeting
The 6th Annual General Meeting is scheduled to be held on Th…
BSE Filing ↗ Board MeetingPPLPHARMA
202423Oct
Board Meeting
Unaudited Financial Results (Standalone and Consolidated) of…
BSE Filing ↗ Board MeetingPPLPHARMA
202410May
Board Meeting
Consider and approve Audited Financial Results (Standalone a…
BSE Filing ↗ Board MeetingPPLPHARMA
202430Jan
Board Meeting
Consider and approve the Unaudited Financial Results for the…
BSE Filing ↗ Board MeetingPPLPHARMA
202327Oct
Board Meeting
Consideration and approval of Unaudited Financial Results (S…
BSE Filing ↗